Importantly, these agents inhibit the migration, proliferation, survival and invasion of human glioblastoma cells, providing additional evidence for the role of RFX1 in regulating the cancer cell behaviour of glioblastoma cells. This evidence concerns the gene RFX1 and glioblastoma.